Our results are consistent with the work of Cao et al. and Schulz et al., who detected GSK-3β as a driving force in tumor cell progression in EOC (Cao et al. 2006) and squamous cell carcinomas of the head and neck (Schulz et al. 2018). Here, GSK3B is linked to squamous cell carcinoma.